4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-23-007032
Director sold 30,000 shares at an average $16.66 ($499,923)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Walker Neal Director | 2023-02-01 | Sale | −25,000 | $16.75 | $418,675 | 1,180,763 | D |
| Walker Neal Director | 2023-02-02 | Sale | −1,079 | $14.57 | $15,718 | 1,179,684 | D |
| Walker Neal Director | 2023-02-02 | Sale | −600 | $15.55 | $9,332 | 1,179,084 | D |
| Walker Neal Director | 2023-02-02 | Sale | −3,121 | $16.88 | $52,691 | 1,175,963 | D |
| Walker Neal Director | 2023-02-02 | Sale | −200 | $17.54 | $3,507 | 1,175,763 | D |
| Open-market sales · 30,000 sh · avg $16.66 · $499,923 | |||||||
Loading xslF345X03/doc4.xml…